Terry Jones

Terry Jones's AcademicInfluence.com Rankings

Terry Jones

Biology

#15331

World Rank

#19285

Historical Rank

Neuroscience

#2743

World Rank

#2814

Historical Rank

biology Degrees

Download Badge

Biology

Terry Jones's Degrees

PhD Neuroscience University of Oxford

Why Is Terry Jones Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Terry Jones's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values (1980) (1264)
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. (2000) (642)
Cerebral Oxygen Metabolism and Blood Flow in Human Cerebral Ischemic Infarction (1982) (395)
Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. (1998) (355)
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 (2000) (252)
[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis (1999) (213)
Fully Three-dimensional Reconstruction For A Pet Camera With Retractable Septa (1990) (208)
In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. (2001) (180)
Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. (1992) (180)
Use of PET Methods for Measurement of Cerebral Energy Metabolism and Hemodynamics in Cerebrovascular Disease (1989) (161)
A Theoretical Study of the Steady‐State Model for Measuring Regional Cerebral Blood Flow and Oxygen Utilisation Using Oxygen‐15 (1981) (153)
Combination of Dynamic and Integral Methods for Generating Reproducible Functional CBF Images (1990) (152)
Correction for scatter in 3D brain PET using a dual energy window method. (1996) (138)
Quantitative Measurement of Regional Extravascular Lung Density Using Positron Emission and Transmission Tomography (1981) (138)
Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. (1984) (136)
A normalization technique for 3D PET data. (1991) (113)
An interictal study of partial epilepsy using positron emission tomography and the oxygen - 15 inhalation technique. (1983) (111)
CMRO2 and CBF by the oxygen-15 inhalation technique. Results in normal volunteers and cerebrovascular patients. (1981) (104)
Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group. (1995) (101)
Correction for scatter using a dual energy window technique with a tomograph operated without septa (1991) (93)
Parametric image reconstruction using spectral analysis of PET projection data. (1998) (92)
A Statistical Study of the Steady State Technique for Measuring Regional Cerebral Blood Flow and Oxygen Utilisation Using 15O (1982) (89)
A cluster analysis approach for the characterization of dynamic PET data (1996) (87)
Measurement of Glucose Utilisation with [18F]2-Fluoro-2-Deoxy-D-Glucose: A Comparison of Different Analytical Methods (1987) (87)
Demonstration of thalamic activation during typical absence seizures using H2(15)O and PET. (1995) (86)
Interrelationships between regional blood flow, blood volume, and ventilation in supine humans. (1994) (86)
In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography. (2001) (85)
Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography (1996) (71)
A study of cerebral blood flow and metabolism in epileptic psychosis using positron emission tomography and oxygen. (1985) (67)
Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. (1985) (66)
Quantification of regional V/Q ratios in humans by use of PET. II. Procedure and normal values. (1989) (62)
In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy. (1996) (59)
Study of regional cerebral metabolism and blood flow relationships in man using the method of continuously inhaling oxygen-15 and oxygen-15 labelled carbon dioxide. (1978) (56)
Glucose Transport across the Blood—Brain Barrier in Normal Human Subjects and Patients with Cerebral Tumours Studied Using [11C]3-O-Methyl-D-Glucose and Positron Emission Tomography (1986) (52)
Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation. (1998) (49)
An investigation of factors affecting detector and geometric correction in normalization of 3-D PET data (1995) (48)
Regional impairment of cerebral oxidative metabolism in Parkinson's disease. (1979) (46)
Quantification of regional V/Q ratios in humans by use of PET. I. Theory. (1989) (42)
Noninvasive Quantification of rCBF Using Positron Emission Tomography (1996) (41)
Assessment of response function in two PET scanners with and without interplane septa. (1991) (40)
2D And 3D Imaging Of Small Animals And The Human Radial Artery With A High Resolution Detector For PET (1990) (37)
Relationships between regional ventilation and vascular and extravascular volume in supine humans. (1994) (37)
Non-invasive regional study of chronic cerebrovascular disorders using the oxygen-15 inhalation technique. (1978) (36)
Regional cerebral oxygen utilization and blood flow in normal man using oxygen‐15 and positron emission tomography (1980) (36)
Experience with fully 3D PET and implications for future high-resolution 3D tomographs. (1998) (34)
Analysis of Dynamic Radioligand Displacement or “Activation” Studies (1997) (33)
Regional structure-function correlations in chronic obstructive lung disease measured with positron emission tomography. (1992) (27)
In vivo quantification of human pulmonary beta-adrenoceptor density using PET: comparison with in vitro radioligand binding. (1996) (26)
Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. (1998) (25)
A method of studying pharmacokinetics in man at picomolar drug concentrations. (1991) (24)
Pulmonary and cardiac beta-adrenoceptor density in vivo in asthmatic subjects. (1997) (22)
New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomography. (1993) (20)
Uneven ventilation within and between regions of the normal measured with nitrogen-13. (1969) (18)
Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients (2002) (18)
In vivo Measurement of the Volume of Distribution of Water in Cerebral Grey Matter: Effects on the Calculation of Regional Cerebral Blood Flow (1992) (18)
Continuous imaging of regional myocardial blood flow in dogs using krypton-81m. (1976) (18)
The direct calculation of parametric images from raw PET data using maximum likelihood iterative reconstruction (1995) (16)
CHAPTER 13 – Development of an On-Line Blood Detector System for PET Studies in Small Animals (1996) (15)
Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting. (1995) (14)
A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC) (1995) (14)
The role of PET scanning in radiotherapy (2005) (11)
In vivo measurements of regional cerebral blood flow and blood volume in patients with brain tumours using positron emission tomography (2005) (11)
Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo. (2000) (11)
Validation of noninvasive quantification of rCBF compared with dynamic/integral method by using positron emission tomography and oxygen-15 labeled water (1995) (11)
Potential for a fifth generation PET scanner for oncology (2005) (9)
Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. (1997) (8)
Three-dimensional reconstruction for a multi-ring positron tomograph. (1991) (8)
Normalisation and reconstruction of PET data acquired by a multi-ring camera with septa retracted. (1991) (8)
An investigation of factors affecting detector and geometric correction in normalisation of 3D PET data (1995) (7)
Uncoupling of Flow and Metabolism in Infarcted Tissue (1985) (7)
Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo (1997) (7)
Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography. (1996) (7)
Cardiac and respiratory gating of list-mode data on a high sensitivity PET scanner, the ECAT EXACT3D (1999) (7)
Dynamic monitoring of [11C]diprenorphine in rat brain using a prototype positron imaging device. (1990) (5)
Chapter 62 - Quantitative Imaging of [ 11 C]Benztropine in the Human Brain with Graphic Analysis and Spectral Analysis (1996) (4)
Influence of Intravascular Activity on the Determination of Blood Flow and Oxygen Extraction in Normal and Ulcerated Legs Using the 15O Steady‐State Technique and Positron Emission Tomography (1985) (4)
Chapter 9 – Neuroimaging (2007) (4)
Implementation of quantitative 3D PET (1991) (4)
CHAPTER 52 – The Analysis of Brain PET Radioligand Displacement Studies (1996) (3)
Clinical Application of Measurement of Regional Cerebral Blood Flow and Oxygen Utilization by Positron Emission Tomography (1983) (3)
3D performance of a small diameter positron emission tomograph for scanning small animals (1995) (2)
Brain PET radioligand displacement studies: modelling 11-C flumazenil displacement by i.v. midazolam in man (1995) (2)
The Disposition of a New Drug Propellant (HFA 134a) in Humans Studied by Fluorine-18 Labelling and Whole-Body γ-Counting (1995) (2)
Trends in Instrumentation (1996) (1)
Reduced adrenoceptor density in vivo in human lung tumours : a preliminary study with positron emission tomography (1)
Positron emission tomography. (1985) (1)
CHAPTER 5 – The MOC Counter: A Pharmacological Tool for the in Vivo Measurement of Ligand Occupancy Indices in the Human Brain (1996) (1)
Parametric Image Reconstruction Using Spectral Analysis of (Rebinned) Three-Dimensional Projection Data 1 1Transcripts of the BRAINPET97 discussion of this chapter can be found in Section VIII. (1998) (1)
31. 18F-fluorodeoxyglucose (FDG) imaging with a 3D, rotating, partial-ring PET scanner (ECAT-ART) (1996) (0)
Measurement of Regional Tissue Physiology Using Positron Emission Tomography (1988) (0)
The MOC counter: a new tool for the in vivo measurement of ligand occupancy ratios in the human brain (1995) (0)
Regional pharmacokinetics in man at picomolar drug concentrations studied by whole-body counting (1992) (0)
IS EPILEPSY CARE IN LOW-GRADE GLIOMA PATIENTS MEETING BEST PRACTICE? (2016) (0)
REGIONAL CEREBRAL BLOOD-FLOW AND OXYGEN-CONSUMPTION IN ACUTE HEMISPHERIC STROKE MEASURED WITH O-15(2) AND POSITRON EMISSION TOMOGRAPHY (1981) (0)
Oxygen 15 Inhalation Technique in the Study of Regional Cerebral Metabolism-to-Blood Flow Relationship in Man (1979) (0)
A NewStrategy fortheAssessment ofViable Myocardium andRegional Myocardial Blood FlowUsing'50-Water andDynamicPositron Emission Tomography (1992) (0)
Comparison study of spectral analysis and weighted integration in [C-11] flumzenil PET (2000) (0)
2-D and 3-D Imaging of Small Animals a High Resolution Detector for PET Radial and the Human Artery with (1992) (0)
Reducedadrenoceptor density invivoin humanlung tumours:apreliminary study with positron emissiontomography (1996) (0)
P-11-32 The multiple objects coincidences counter (MOCC) — a new tool for the measurement of ligand tissue occupancy in vivo in man (1995) (0)

This paper list is powered by the following services:

Terry Jones's Academic­Influence.com Rankings

Terry Jones's Degrees

Why Is Terry Jones Influential?

Terry Jones's Published Works

Published Works

Terry Jones's AcademicInfluence.com Rankings